SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-009046
Filing Date
2014-05-14
Accepted
2014-05-14 15:53:12
Documents
17
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ahro20140331_10q.htm 10-Q 753863
2 EXHIBIT 10.1 ex10-1.htm EX-10 102263
3 EXHIBIT 10.2 ex10-2.htm EX-10 103860
4 EXHIBIT 10.3 ex10-3.htm EX-10 226577
5 EXHIBIT 10.4 ex10-4.htm EX-10 47544
6 EXHIBIT 10.5 ex10-5.htm EX-10 92255
7 EXHIBIT 10.6 ex10-6.htm EX-10 46773
8 EXHIBIT 31.1 ex31-1.htm EX-31 16980
9 EXHIBIT 31.2 ex31-2.htm EX-31 16998
10 EXHIBIT 32.1 ex32-1.htm EX-32 6999
11 EXHIBIT 32.2 ex32-2.htm EX-32 7512
  Complete submission text file 0001437749-14-009046.txt   5649356

Data Files

Seq Description Document Type Size
12 EXHIBIT 101.INS ahro-20140331.xml EX-101.INS 638181
13 EXHIBIT 101.SCH ahro-20140331.xsd EX-101.SCH 48036
14 EXHIBIT 101.CAL ahro-20140331_cal.xml EX-101.CAL 28829
15 EXHIBIT 101.DEF ahro-20140331_def.xml EX-101.DEF 237353
16 EXHIBIT 101.LAB ahro-20140331_lab.xml EX-101.LAB 376262
17 EXHIBIT 101.PRE ahro-20140331_pre.xml EX-101.PRE 235497
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52315 | Film No.: 14841374
SIC: 2834 Pharmaceutical Preparations